Aeva Technologies, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023; filed March 15, 2024. This is an annual filing, not a standalone Q4 report, and it does not provide clear Q4-only financial results.
Business context
Aeva develops FMCW-based 4D LiDAR sensing systems and software for automotive, industrial automation, consumer and security applications. Revenue to date has primarily come from prototype sales and non-recurring engineering services; the company had not begun commercial production deliveries as of the filing. It reported 301 full-time employees at year-end.
Key financial metrics
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $4.3 million | $4.2 million |
| Cost of revenue | $10.2 million | $8.4 million |
| Gross loss | $5.9 million | $4.3 million |
| Operating expenses | $141.9 million | $147.7 million |
| Operating loss | $147.8 million | $152.0 million |
| Net loss | $149.3 million | $147.3 million |
| Net loss per share, basic and diluted | $0.66 | $0.68 |
| Cash used in operating activities | $118.8 million | $109.9 million |
Revenue grew 3%, principally from more prototype units, partly offset by lower engineering-services activity. Cost of revenue rose 21%, and gross loss widened. Research and development expense fell 6% to $102.5 million, while general and administrative expense increased 2% and sales and marketing expense increased 8%. Operating loss improved, but net loss worsened modestly, primarily reflecting $10.5 million of net other expense, including warrant-related fair-value expense and financing costs. Interest income increased to $8.9 million from $3.7 million.
At December 31, 2023, cash and cash equivalents were $38.5 million and marketable securities were $182.5 million, totaling approximately $221.0 million. Total assets were $257.4 million and stockholders’ equity was $228.4 million. The filing reports no conventional borrowings; lease liabilities totaled $7.4 million. Management said available cash, cash equivalents and marketable securities should fund operating and capital needs for at least 12 months from issuance of the financial statements, but additional capital may be needed absent sufficient product revenue.
Material changes and financing
- Cash and marketable securities declined from $323.8 million at year-end 2022 to $221.0 million at year-end 2023. Operating cash use increased, while investing cash inflow primarily reflected maturities of securities.
- A November 2023 private placement issued 36.8 million common shares for approximately $20.6 million net proceeds.
- A standby equity purchase agreement gives Aeva the option to sell up to $125 million of preferred stock to Sylebra through November 2026, subject to conditions, including a qualifying new OEM program award. Any issued preferred stock would carry a 7% annual dividend and senior liquidation preference; draws could materially dilute common shareholders.
- Aeva issued 15 million Series A warrants exercisable at $1 per share. At year-end, 27.5 million common-stock warrants were outstanding in total, including 12.5 million with an $11.50 exercise price. Equity awards and warrants add further potential dilution.
Outlook, risks and unusual items
- Management expects 2024 operating expenses to remain similar to, or increase slightly from, 2023 levels. The filing says commercial product deliveries were not expected in 2024 and may not occur at all.
- In January 2024, Daimler Truck selected Aeva as a LiDAR supplier for an autonomous commercial-vehicle program. Collaboration was expected to begin in Q1 2024, with Aeva production expected from 2026 and Daimler Truck’s ramp anticipated from 2027. The selection does not guarantee volume orders or revenue.
- Aeva announced Atlas, a new automotive-targeted 4D LiDAR, in January 2024. Commercial adoption, customer validation, program timing and production volumes remain uncertain.
- Principal risks include continuing losses and cash burn; lengthy development and validation cycles; dependence on a small number of customers (the top two represented 45% of FY2023 revenue); customer cancellations or delays; competition and pricing pressure; scaling outsourced manufacturing and supply-chain constraints; product reliability and liability; and potential need for additional capital.
- A Delaware stockholder disclosure suit was dismissed as moot after supplemental disclosures; Aeva agreed to pay $350,000 in attorneys’ fees and expenses, accrued in 2023. A separate 2024 suit against former InterPrivate parties does not name Aeva or its current directors and officers.
- A 1-for-5 reverse stock split was announced in March 2024, after year-end, in response to an NYSE minimum-bid-price deficiency. The filing also reports Rule 10b5-1 plans adopted by the CEO and CTO that may permit sales of up to 4.0 million and 4.65 million shares, respectively, on the stated schedules.
- The auditor issued an unqualified opinion on the financial statements. Management concluded disclosure controls and internal control over financial reporting were effective at year-end; the auditor did not attest to internal-control effectiveness.
Investor verification priorities
- Confirm the latest cash, securities, cash-burn rate and management’s funding runway, including whether the Sylebra facility’s conditions can be met and what its preferred-stock terms would mean for common shareholders.
- Track customer validation, binding production agreements, program timing and actual order volumes—especially for Daimler Truck—and distinguish announced selections from firm purchase commitments.
- Review quarterly revenue mix, gross margins, operating expenses and customer concentration as prototype and engineering revenue transitions, if at all, to production sales.
- Assess potential dilution from the private placement, warrants, equity awards, any facility draw and the reverse split’s adjusted share counts and prices.
- Monitor NYSE listing compliance, the disclosed insider trading plans, and developments in the legal matters and product/manufacturing risks.